Food antigen activates intraepithelial and lamina propria lymphocytes in food-sensitive enteropathy in mice.
Morphologic and immunologic changes in the gut mucosa of food-hypersensitive mice, from a study model generated by feeding ovalbumin (OVA) to female BALB/c mice after intraperitoneal injection of cyclophosphamide (CY), were investigated in an effort to clarify the mechanisms of food-sensitive enteropathy. Villous atrophy, crypt hyperplasia, and increased numbers of intraepithelial lymphocytes (IEL) were confirmed in the antigen-challenged OVA-sensitive mice as seen in food-sensitive enteropathy in humans, whereas no significant morphologic changes were observed in the nontreated control group or groups treated with OVA or CY alone. IEL and lamina propria lymphocytes (LPL) were isolated from the intestinal mucosa before and after the antigen challenge, and surface markers were analyzed by FACScan. After the antigen challenge, the numbers of CD8+ cells increased among the IEL, and the occurrence of both CD4+ and CD8+ cells increased among the LPL. The numbers of Thy-1+ cells and TCR- alpha/beta + cells increased among both the IEL and LPL, and LFA-1 expression was enhanced in both of these lymphocyte populations. The proliferative response of IEL and LPL to OVA increased in a dose-dependent manner after the antigen challenge in the OVA-sensitive mouse model. These results indicate that IEL and LPL, possibly those that have migrated from peripheral blood, are activated by orally administered antigens and cause mucosal damage in the food-sensitive enteropathy.
Ohtsuka
Y
Y
Department of Pediatrics, Juntendo University School of Medicine, Tokyo, Japan.
Yamashiro
Y
Y
Maeda
M
M
Oguchi
S
S
Shimizu
T
T
Nagata
S
S
Yagita
H
H
Yabuta
K
K
Okumura
K
K
D000818:Animals; D000941:Antigens / Q000008:administration & dosage*; D001284:Atrophy; D004195:Disease Models, Animal; D005260:Female; D005512:Food Hypersensitivity / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D006965:Hyperplasia; D066298:In Vitro Techniques; D007410:Intestinal Diseases / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D007413:Intestinal Mucosa / Q000276:immunology / Q000473:pathology; D007583:Jejunum / Q000276:immunology / Q000473:pathology; D008213:Lymphocyte Activation; D051379:Mice; D008807:Mice, Inbred BALB C; D010047:Ovalbumin / Q000276:immunology*; D016176:T-Lymphocyte Subsets / Q000276:immunology
D000941:Antigens; D010047:Ovalbumin